Services we provide
Services we provide
New drug development and drug repositioning based on a successful model
A big change is under way in pharma industries in the world. We propose a new concept that the most critical step is the evaluation of the probability of success of a seed, and this can be efficiently overcome by use of the results from genomic analyses of diseases.
Clinical Research Supporting Business
Importance of clinical researches to optimize the treatment strategies has recently been recognized. A rather large organization is required for a clinical research. Human resources needed include the employees for data acquisition, data input, data cleaning and data analysis. StaGen has sufficient achievements in the support business for clinical research.
Analysis of the data from next generation sequencers
StaGen Co. Ltd has a lot of experiences of the analyses of the data from various next-generation sequencers sold by Illumina Inc. and Life Technologies Inc. Based on such experiences, we provide consultations concerning the selection of the machines, important points for the preparation of the samples, installation of the computer systems, installation of necessary pipelines and data analysis from the beginning.
Healthcare ICT business
Smart phones and wearable devices are the most convenient communication tools of individuals. We promote a healthcare business using those devices that most of individuals carry and get important data from.
Support for Genome-Wide Association Study
StaGen Co. Ltd, a specialized group in medicine, genetics, statistics and informatics, has a plenty of experience in the analyses of GWAS data from academy and pharmaceutical companies. Future focuses of GWAS include those for rare diseases whose causes are yet unknown and application from research field to real practice, such as new drug development. Please consult us about the analysis of your valuable GWAS data.
Support for Genomic Studies in Animals and Plants
StaGen Co. Ltd evaluates and predicts the genetic ability based on sophisticated statistical genetics using QTL data from various agricultural products, cattle and experimental animals.
StaGen Co. Ltd is one of a few companies that can provide the knowledge required to understand genomic data. We can provide a wide variety of curriculums suited to the clients beginning from the provision of basic knowledge to that of specialized knowledge of statistical genetics and genome-based new drug development.
Support for Clinical Trials Including Genomic Information
Because of the development of advanced technologies to obtain genomic information and the establishment of ethical guidelines for genomic research, more and more clinical trials include genomic information to make the development of new drugs more efficient and safer. StaGen Co. Ltd has a lot of experiences in analyzing genomic data in clinical trials.
We hold or have applied for three types of patents. First for genomic tests for the prediction of the effects and adverse events of drugs (pharmacogenomics), second for healthcare business using smart phones and wearable devices (healthcare ICT) and the last for new drug development.